Controlled substances
FY 2021 MDSP - Expanding Targeted Gas Chromatography Mass Spectrometry (GC-MS) Capabilities for Controlled Substance Analysis
The analysis of commercially available natural products recommended for use in electronic cigarettes
The characterization of isobaric product ions of fentanyl using multi-stage mass spectrometry, high-resolution mass spectrometry and isotopic labeling
Legalization of Marijuana: The Journey of Marijuana Laws in Colorado and Ohio
Integrating SERS and PSI-MS with Dual Purpose Plasmonic Paper Substrates for On-Site Illicit Drug Confirmation
Identification of five mitragyna alkaloids in blood and tissues using liquid chromatography-quadrupole/time-of-flight mass spectrometry
Can Jury Instructions Have an Impact on Trial Outcomes?
MicroCantilever (MC) based Robust Sensing Approach for Controlled Substances
Assessment of the Contribution to Drug Impaired Driving from Emerging and Undertested Drugs
Validation of a LC-DAD-ESI/MS/MS method for the accurate measurement of THC and THCA-A among twenty cannabinoids in various products of Cannabis
Efficient Casework Policy To Address Emerging Challenges in Seized Drugs
The substances tested in cases involving seized drugs are always evolving. By establishing policies on the most critical samples to test and maintaining ongoing communication with stakeholders, laboratories can more efficiently manage a backlog.